OPKO's Frost: BioReference Was a Tremendous Acquisition (Audio)

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Dr. Philip Frost, Chairman and CEO of OPKO Health, on the current landscape for the biotech industry, the company product pipeline, and drug pricing.See omnystudio.com/listener for privacy information.